Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.61 |
| ▸ | CA1 | P00915 | 5/20 | 0.61 |
| ▸ | CA12 | O43570 | 5/20 | 0.61 |
| ▸ | CA9 | Q16790 | 5/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.61 |
| ▸ | CA3 | P07451 | 2/20 | 0.61 |
| ▸ | CA6 | P23280 | 2/20 | 0.61 |
| ▸ | CA5A | P35218 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 2/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7053219 | 0.98 | CA2 (0.59) | CA2CA1CA12CA9CA14 | |
| Hydrochloric Acid SCHEMBL35156 | 0.98 | CA2 (0.59) | CA2CA1CA12CA9CA14 | |
| SCHEMBL1729812 | 0.85 | CA1 (0.51) | CA2CA1CA12CA9CA14 | |
| SCHEMBL18547450 | 0.85 | SRD5A2 (0.62) | CA2CA1CA12CA9CA14 | |
| SCHEMBL7917653 | 0.83 | ALDH1A1 (0.50) | CA2CA1CA12CA9CA14 | |
| SCHEMBL35155 | 0.81 | ALDH1A1 (0.48) | CA2CA1CA12CA9CA14 | |
| SCHEMBL28554454 | 0.81 | ALDH1A1 (0.48) | CA2CA1CA12CA9CA14 | |
| SCHEMBL9822529 | 0.80 | ALDH1A1 (0.60) | CA2CA1CA12CA9CA14 | |
| SCHEMBL2917437 | 0.80 | CA1 (0.67) | CA2CA1CA12CA9CA14 | |
| SCHEMBL22349 | 0.80 | CA1 (0.67) | CA2CA1CA12CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118772112-B | PROTAC medicine molecule targeting Fam20C as well as preparation method and application thereof | 西南交通大学 | 2025-04-01 | — | — | CN | claimed |
| CN-118772112-A | PROTAC medicine molecule targeting Fam20C as well as preparation method and application thereof | 西南交通大学 | 2024-10-15 | — | — | CN | claimed |
| CN-117298108-A | Androgen receptor and glucocorticoid receptor dual-target inhibitor and application thereof | 浙江师范大学 | 2023-12-29 | — | — | CN | claimed |
| CN-117285922-A | Integrated variable-viscosity fracturing fluid and preparation method thereof | 山东普瑞思德石油技术有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-115109011-B | Benzothiazole compound, preparation method and application | 河北师范大学 | 2023-12-15 | — | — | CN | claimed |
| CN-115109011-A | Benzothiazole compound, preparation method and application | 河北师范大学 | 2022-09-27 | — | — | CN | claimed |
| CN-113908589-B | Hydrophobic charge induction mode membrane chromatography medium of surface imprinted antibody and preparation method thereof | 天津工业大学 | 2022-09-27 | — | — | CN | claimed |
| CN-113908589-A | Hydrophobic charge induction mode membrane chromatography medium for surface imprinted antibody and preparation method thereof | 天津工业大学 | 2022-01-11 | — | — | CN | claimed |
| CN-106832783-B | Toughening modification method of epoxy resin | 中冶建筑研究总院有限公司 | 2020-01-07 | — | — | CN | claimed |
| CN-107056768-A | A kind of reversible proton pump inhibitor, preparation method and applications | 三峡大学 | 2017-08-18 | — | — | CN | claimed |
| CN-101801949-A | Sulfonamides as TRPM8 modulators | JANSSEN PHARMACEUTICA NV | 2010-08-11 | — | — | CN | claimed |
| EP-2183239-A1 | SULFONAMIDES AS TRPM8 MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2010-05-12 | — | — | EP | claimed |
| EP-1308540-B1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY CO LLC (US) | 2010-01-20 | — | — | EP | claimed |
| US-20090264474-A1 | SULFONAMIDES AS TRPM8 MODULATORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2009-10-22 | — | — | US | claimed |
| WO-2009012430-A1 | SULFONAMIDES AS TRPM8 MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-01-22 | — | — | WO | claimed |
| WO-2006011719-A1 | N-SUBSTITUTED-SULFAMOYLBENZOIC ACID DERIVATIVES, METHOD FOR PREPARING THEREOF AND ANTIVIRAL PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | B & C BIOPHARM CO., LTD. (KR) | 2006-02-02 | — | — | WO | claimed |
| US-20040104124-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2004-06-03 | — | — | US | claimed |
| US-6736954-B2 | A METAL PLATING BATH COMPRISING METAL SALTS AND AN ADDITIVE CONSUMPTION INHIBITOR(A HETEROATOM ORGANIC COMPOUNDS WHICH MAY CONTAIN SULFUR, OXYGEN OR NITROGEN HETEROATOMS) IMPROVE THE BRIGHTNESS OF PLATED METAL AS WELL AS THE DUCTILITY | SHIPLEY COMPANY, L.L.C. | 2004-05-18 | — | — | US | claimed |
| EP-1308540-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-05-07 | — | — | EP | claimed |
| US-20030070934-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2003-04-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264474-A1 | SULFONAMIDES AS TRPM8 MODULATORS | TRPM8, TRPM5, TRPM2 | CA2 264/4885CA1 1538/4885CA12 2056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.